For many years, ALL has responded to changing needs for better healthcare. Our medicines aim to bring longer lives and healthier living to people all over the world.
Our medicines are enabling people whose lives have been disrupted by an illness to return comfortably to their regular activities. They are helping people to live more easily with their 21st century environment.
Our scientists are continuing to seek new solutions to the challenges that are facing today's healthcare providers.
ALL has a deep heritage in neurology, providing a range of solutions for people living with neurological disorders, including epilepsy and Parkinson’s disease. We are committed to expanding our leadership and capabilities into new frontiers with substantial unmet needs.
At ALL, we embrace the possibility to create a world free from the burden of immune-mediated inflammatory diseases. Relapsing and remitting in nature, these diseases place a huge strain on patients and their support systems. While there have been advancements in recent years, significant unmet needs remain.
